doi: 10.1161/01.RES.0000225258.53189.dc
© 2006 American Heart Association, Inc.
Letters to the Editor |
Progenitor Cells and Valve Degeneration
Department of Cardiology, University of Bonn, Germany
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
To the Editor:
We read with great interest the study by Visconti et al,1 that tested in a mice model whether hematopoietic stem cells (HSCs) may contribute to cardiac valve interstitial cells. Based on the finding that HSC-derived cells within the valves exhibited synthetic properties characteristic of fibroblasts, the investigators concluded that HSCs are a source of valve fibroblasts. These exciting data add another piece of evidence to the concept that apparently not tissue resident cells, but other cell types play a more central role in valvular replenishment and repair.
In this context, we recently identified endothelial progenitor cells (EPCs) and dendritic cells (DCs)—possibly also originating from hemotopoietic stem cells—in human degenerative aortic valves, more frequently in bioprostheses than in native cusps.2 The localization of these cells close to the aortoluminal border per se suggests circulating progenitor cells as the source of these cells, as recently shown by longitudinal animal work in traumatized rat carotid arteries.3 This is also supported by the observation that glutaraldehyde-treated tissue valves, typically devoid of intact cells at the time of implantation, showed a de novo cellularity of 
650 cells per mm2 at explantation.2 As suggested by Visconti et al, the presence of primarily extravalvular cells in aortic valves may indicate a response to valve injury. Indeed, our data show strong colocalization with inflammatory cells2 and with C-reactive protein.4 The proinflammatory stimuli that are continuously present on susceptible cusps and impede with permanent blood flow and its pathogenic burden may promote EPC mobilization and homing.